Clinical Trial Update: Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection [NA]

View source ↗

Summary

Clinical trial update reporting safety and performance of the COR-VG-001 conduit in pediatric patients undergoing extracardiac total cavopulmonary connection; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Defects Congenital

Drugs mentioned

• COR-VG-001 conduit

Snippet

Sponsor: Xeltis | Conditions: Heart Defects, Congenital | NA | Status: COMPLETED | Results posted: 2020-11-10